The annual ACTRIMS/ECTRIMS conference took place September 11-13, and Multiple Sclerosis News Today summarizes one of the presentations there that may be of interest here since some people here take Rituxan. The article title is "Low Rituximab Doses Safer, as Effective as Higher Ones" (September 14):
Only registered and activated users can see links., Click Here To Register...
ACTRIMS = Americas Committee for Treatment and Research in Multiple Sclerosis
ECTRIMS = European Committee for Treatment and Research in Multiple Sclerosis
Only registered and activated users can see links., Click Here To Register...
ACTRIMS = Americas Committee for Treatment and Research in Multiple Sclerosis
ECTRIMS = European Committee for Treatment and Research in Multiple Sclerosis